These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ventricular fibrillation and its recurrence in early acute myocardial infarction. Logan KR; McIlwaine WJ; Adgey AA; Pantridge JF Lancet; 1981 Jan; 1(8214):242-4. PubMed ID: 6109900 [TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis following ventricular fibrillation in acute ischaemic heart disease. McNamee BT; Robinson TJ; Adgey AA; Scott ME; Geddes JS; Pantridge JF Br Med J; 1970 Oct; 4(5729):204-6. PubMed ID: 5472781 [TBL] [Abstract][Full Text] [Related]
4. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. Schaffer WA; Cobb LA N Engl J Med; 1975 Aug; 293(6):259-62. PubMed ID: 1138178 [TBL] [Abstract][Full Text] [Related]
5. Risk-benefit stratification as a guide to lidocaine prophylaxis of primary ventricular fibrillation in acute myocardial infarction: an analytic review. Goldman L; Batsford WP Yale J Biol Med; 1979; 52(5):455-66. PubMed ID: 392960 [TBL] [Abstract][Full Text] [Related]
8. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ; Easley AR; Mann DE Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228 [TBL] [Abstract][Full Text] [Related]
11. The effects of practolol on the dysrhythmias complicating acute ischemic heart disease. Allen JD; Pantridge JF; Shanks RG Am J Med; 1975 Feb; 58(2):199-208. PubMed ID: 1115067 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Hellestrand KJ Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822 [No Abstract] [Full Text] [Related]
15. [Multi-recurrent cardiac arrest: when to discontinue cardiopulmonary resuscitation?]. Perpoint T; Peillon D; Chambost M; David G; Royon O; Combe C Ann Fr Anesth Reanim; 2000 Mar; 19(3):195-7. PubMed ID: 10782244 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms contributing to dysrhythmias induced by ischemia and their therapeutic implications. Corr PB; Sobel BE Adv Cardiol; 1978; (22):110-29. PubMed ID: 22992 [No Abstract] [Full Text] [Related]
17. [Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation]. Szmydt W; Brodzińska K; Luczak J Pol Tyg Lek; 1971 Jan; 26(3):99-101. PubMed ID: 5545841 [No Abstract] [Full Text] [Related]
18. Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine. Kertes P; Hunt D Br Heart J; 1984 Sep; 52(3):241-7. PubMed ID: 6380549 [No Abstract] [Full Text] [Related]
19. Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy. Denes P; Gabster A; Huang SK Am J Cardiol; 1981 Jul; 48(1):9-16. PubMed ID: 7246449 [TBL] [Abstract][Full Text] [Related]
20. Is all ventricular fibrillation the same? A comparison of ischemically induced with electrically induced ventricular fibrillation in a porcine cardiac arrest and resuscitation model. Niemann JT; Rosborough JP; Youngquist S; Thomas J; Lewis RJ Crit Care Med; 2007 May; 35(5):1356-61. PubMed ID: 17414084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]